Form 4 for LCTX Lineage Cell Therapeutics, Inc.
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-08 · accession 0001493152-24-005510 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-08 | 2024-02-08 | LCTX | BAILEY DON M | Dir | P - Purchase | $1.04 | +96.2K | 158.8K | +153% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, no par value | 2024-02-08 | P | A | 96,155 | $1.04 | 158,801 | I By The Bailey Family Trust | — | — | (F1) Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report. |